Skip to main content

Exploring Biologics to Drive NK Cell Immunotherapy in Mouse Models of Human Cancer

Published Date

In this webinar, we explore:

  • NK cell immunotherapy and how we are using in vitro and in vivo models to test them
  • Different biologics (primarily TriKEs) and xenogeneic mouse models of human cancer employed to test them (AML, prostate cancer, head and neck cancer, lung cancer, and ovarian cancer)
  • Humanized mouse models that can be leveraged to better explore NK cell therapeutics and immune interactions